Balance Sheet Data
Reata Pharmaceuticals, Inc. (RETA)
$172.36
+0.04 (+0.00%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 337.79 | 664.32 | 818.15 | 590.26 | 387.51 | 88.83 | 51.12 | 29.42 | 16.93 | 9.74 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | - | - | 22.23 | 28.32 | 5.46 | 3.14 | 1.81 | 1.04 | 0.60 | 0.34 |
| Account Receivables (%) | ||||||||||
| Inventories | - | - | -22.23 | -28.32 | -5.46 | -3.14 | -1.81 | -1.04 | -0.60 | -0.34 |
| Inventories (%) | ||||||||||
| Accounts Payable | 4.47 | 1.91 | 4.79 | 13.51 | 18.71 | 2.63 | 1.51 | 0.87 | 0.50 | 0.29 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -0.68 | -2.67 | -0.93 | -1.33 | -3.27 | -0.46 | -0.27 | -0.15 | -0.09 | -0.05 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.